Beyond a liver-gut focus: the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigm

被引：6
|
作者：
Brennan, Paul N. [1 ,2 ]
Zelber-Sagi, Shira [3 ]
Allen, Alina M. [4 ]
Dillon, John F. [1 ,2 ]
Lazarus, Jeffrey, V [5 ,6 ]
机构：
[1] Univ Dundee, Ninewells Hosp & Med Sch, Div Mol & Clin Med, Dundee, Scotland
[2] Ninewells Hosp & Med Sch, Dept Gastroenterol, NHS Tayside, Dundee, Scotland
[3] Univ Haifa, Fac Social Welf & Hlth Sci, Sch Publ Hlth, Haifa, Israel
[4] Mayo Clin, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN USA
[5] CUNY Grad Sch Publ Hlth & Hlth Policy CUNY SPH, New York, NY 10027 USA
[6] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth Isglobal, Barcelona, Spain
来源：
GUT | 2024年 / 73卷 / 04期
关键词：
OBESITY; FATTY LIVER; NONALCOHOLIC STEATOHEPATITIS; MANAGEMENT; WEIGHT;
D O I：
10.1136/gutjnl-2023-330771
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：560 / 563
页数：4
相关论文
共 50 条
  • [1] Practice Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease by the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN)
    Sood, Vikrant
    Alam, Seema
    Nagral, Aabha
    Srivastava, Anshu
    Deshmukh, Aniket
    Bavdekar, Ashish
    Acharyya, Bhaswati C.
    Geetha, S. M.
    Gupte, Girish
    Bhatia, Ishitaa
    Tiwari, Kritika
    Bharadia, Lalit
    Sathiyasekaran, Malathi
    Kaur, Prabhsaran
    Khanna, Rajeev
    Shrivastava, Rimjhim
    Poyekar, Samriddhi
    Pandey, Snehavardhan
    Ramakrishna, Somashekara Hosaagrahara
    Kinjawadekar, Upendra
    Borkar, Vibhor
    Sivaramakrishnan, Viswanathan M.
    Kohli, Rohit
    Matthai, John
    Dhawan, Anil
    INDIAN PEDIATRICS, 2024, 61 (10) : 919 - 934
  • [2] NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice
    Cavallari, Joseph F.
    Pokrajac, Nenad T.
    Zlitni, Soumaya
    Foley, Kevin P.
    Henriksbo, Brandyn D.
    Schertzer, Jonathan D.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2020, 319 (02): : E305 - E314
  • [3] Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges
    Saenz, Ernesto
    Montagut, Nathally Espinosa
    Wang, Baohong
    Stein-Thoeringer, Christoph
    Wang, Kaicen
    Weng, Honglei
    Ebert, Matthias
    Schneider, Kai Markus
    Li, Lanjuan
    Teufel, Andreas
    ENGINEERING, 2024, 40 : 51 - 60
  • [4] The gut-liver axis and metabolic dysfunction-associated steatotic liver disease
    Demir, Muenevver
    Tacke, Frank
    Mueller-Schilling, Martina
    Schmid, Stephan
    GASTROENTEROLOGIE, 2025,
  • [5] Involvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A
    Owaki, Takashi
    Kamimura, Kenya
    Ko, Masayoshi
    Nagayama, Itsuo
    Nagoya, Takuro
    Shibata, Osamu
    Oda, Chiyumi
    Morita, Shinichi
    Kimura, Atsushi
    Sato, Takeki
    Setsu, Toru
    Sakamaki, Akira
    Kamimura, Hiroteru
    Yokoo, Takeshi
    Terai, Shuji
    DISEASE MODELS & MECHANISMS, 2022, 15 (07)
  • [6] Nonpharmacological Childhood Obesity Management in Denmark Reduces Steatotic Liver Disease and Obesity
    Pedersen, Rebecca Berg
    Fraulund, Maria Martens
    Chabanova, Elizaveta
    Holm, Louise Aas
    Hansen, Torben
    Thomsen, Henrik S.
    Holm, Jens-Christian
    Fonvig, Cilius Esmann
    CHILDHOOD OBESITY, 2025,
  • [7] A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease
    Martinez-Sanz, Javier
    Talavera-Rodriguez, Alba
    Diaz-Alvarez, Jorge
    Rosas Cancio-Suarez, Marta
    Rodriguez, Juan Miguel
    Alba, Claudio
    Montes, Maria Luisa
    Martin-Mateos, Rosa
    Burgos-Santamaria, Diego
    Moreno, Santiago
    Serrano-Villar, Sergio
    Sanchez-Conde, Matilde
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] Metabolic dysfunction-associated steatotic liver disease: Evolution of the final terminology
    Portincasa, Piero
    Baffy, Gyorgy
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 124 : 35 - 39
  • [9] Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Scarpellini, Emidio
    Scarcella, Marialaura
    Tack, Jan F.
    Scarlata, Giuseppe Guido Maria
    Zanetti, Michela
    Abenavoli, Ludovico
    ANTIOXIDANTS, 2024, 13 (11)
  • [10] Liver tissue lipids in metabolic dysfunction-associated steatotic liver disease with diabetes and obesity
    Sourianarayanane, Achuthan
    Brydges, Christopher R.
    McCullough, Arthur J.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (07)
12345